论文部分内容阅读
本文介绍了美国由脑卒中临床研究者、药物和医疗器械研发相关人士以及政府监管人员组成的三方代表召开卒中治疗圆桌会议(Stroke Therapy Academic Industry Roundtable,STAIR),此会议就急性缺血性脑卒中临床试验研究进行商讨,并提出推荐意见。推荐意见每两年在《Stroke》杂志发表1次。迄今,该会议共召开了8次,其推荐意见对近年来缺血性脑血管病治疗的临床前及临床试验研究起到了重要的指导作用。
This article describes the Stroke Therapy Academic Industry Roundtable (STAIR) held in the United States by tripartite representatives of stroke clinicians, people involved in the development of pharmaceuticals and medical devices, and government regulators. The conference discussed the issue of acute ischemic stroke Clinical trial research to discuss and make recommendations. The recommendations are published every two years in Stroke magazine. So far, a total of eight sessions have been held and its recommendations have played an important guiding role in the preclinical and clinical trial of treatment of ischemic cerebrovascular diseases in recent years.